Dr. Sameer Ahmed Alvi, MD

Dr. Alvi practices at Northshore University Healthsystem - HOPD in Northbrook, Illinois.

Dr. Alvi's NPI, 1619311875, was assigned on April 18, 2013. Dr. Alvi graduated from University of Missouri, Kansas City, School of Medicine in 2013. Dr. Alvi holds Illinois license 036146139.

Dr. Alvi's primary practice is Northshore University Healthsystem - HOPD, at 501 Skokie Boulevard, Northbrook, IL 60062.

Dr. Alvi's primary practice is Northshore University Healthsystem - HOPD in Northbrook, Illinois. Dr. Alvi is also affiliated with Evanston Hospital. The medical group on file is Endeavor Health Medical Group. Dmand AI also links Dr. Alvi to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Alvi's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alvi practices, 5 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Alvi's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Alvi is licensed in Illinois.

CMS data shows 698 Medicare services from Dr. Alvi across 8 procedure codes in 2024, for 466 Medicare patients. Medicare paid $48,570 for them. Every service was in an office.

CMS counts 466 Medicare patients who saw Dr. Alvi in 2024. The largest group is 65 to 74, with 193 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.62, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alvi's median patient age at 69, with 49% women.

In 2024, Dr. Alvi wrote 80 Medicare Part D claims for 47 patients. 98% of them were for generic drugs. CMS names the drug for 30 of them, across 1 drug with 11 or more claims each, at $1,098 in total drug cost. In 2023, CMS named 90 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Alvi for performance year 2024, reported as part of a group. Dr. Alvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Alvi as offering telehealth. CMS counts 30 procedures of melanoma (skin cancer) excision by Dr. Alvi, more than 80% of the clinicians it reports for that procedure.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 23 papers to Dr. Alvi, published from 2017 to 2023. 2018 was the busiest year, with 9. The most frequent topics are Carcinoma, Squamous Cell, Head and Neck Neoplasms and Mouth Neoplasms. Dr. Alvi has published most often in Ann Otol Rhinol Laryngol. Dr. Alvi's most frequent co-authors are Kiran Kakarala, MD, Bledi Brahimaj, MD and Richard W. Byrne, MD.

CMS Open Payments shows 28 general payments to Dr. Alvi from 10 drug and device companies from 2016 to 2025. Education make up the largest share, 66% of the total. Intuitive Surgical, Inc. paid the most, $4,881.

Dr. Alvi graduated from University of Missouri, Kansas City, School of Medicine in 2013.